Inhibition of Bruton's tyrosine kinase regulates macrophage NF-κB and NLRP3 inflammasome activation in metabolic inflammation

Inhibition of Bruton's tyrosine kinase regulates macrophage NF-κB and NLRP3 inflammasome activation in metabolic inflammation

Background and Purpose Currently there are limited medicines available for the treatment of metabolic inflammation in diseases such as obesity and type 2 diabetes (T2D). Although initially associated with B‐ells, Bruton's tyrosine kinase (BTK) is present in a wide variety of cells including mon...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Purvis, GSD, Collino, M, Aranda-Tavio, H, Chiazza, F, O'Riordan, CE, Zeboudj, L, Mohammad, S, Collotta, D, Verta, R, Guisot, NES, Bunyard, P, Yaqoob, MM, Greaves, DR, Thiemermann, C
Natura:	Journal article
Lingua:	English
Pubblicazione:	Wiley 2020

Documenti analoghi

Bruton's tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice
di: O'Riordan, CE, et al.
Pubblicazione: (2019)

X-linked immunodeficient mice with no functional Bruton's tyrosine kinase are protected from sepsis-induced multiple organ failure
di: O'Riordan, CE, et al.
Pubblicazione: (2020)

Bruton's TK regulates myeloid cell recruitment during acute inflammation
di: Purvis, GSD, et al.
Pubblicazione: (2022)

Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice
di: Caroline E. O'Riordan, et al.
Pubblicazione: (2019-09-01)

Brutinib has anti‐inflammatory and anti‐diabetic effects in a model of HFD‐ induced insulin resistance and diabetic nephropathy
di: Purvis, GS, et al.
Pubblicazione: (2019)

X-Linked Immunodeficient Mice With No Functional Bruton's Tyrosine Kinase Are Protected From Sepsis-Induced Multiple Organ Failure
di: Caroline E. O'Riordan, et al.
Pubblicazione: (2020-10-01)

The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
di: Elisa Benetti, et al.
Pubblicazione: (2013-01-01)

Evidence for interaction of the NLRP3 inflammasome and Bruton’s tyrosine kinase in tumor-associated macrophages: implications for myeloid cell production of interleukin-1beta
di: Brooke Benner, et al.
Pubblicazione: (2019-11-01)

Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κB
di: Sura Al Zoubi, et al.
Pubblicazione: (2018-12-01)

RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearance
di: Chen, J, et al.
Pubblicazione: (2020)

Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice
di: Debora Collotta, et al.
Pubblicazione: (2020-09-01)

Inhibition of IκB Kinase at 24 hours after acute kidney injury improves recovery of renal function and attenuates fibrosis
di: Johnson, F, et al.
Pubblicazione: (2017)

NLRP inflammasomes in health and disease
di: Zhihao Xu, et al.
Pubblicazione: (2024-04-01)

Inhibiting the NLRP3 Inflammasome
di: Lina Y. El-Sharkawy, et al.
Pubblicazione: (2020-11-01)

Expression of Bruton's tyrosine kinase in osteoclasts
di: Danks, L, et al.
Pubblicazione: (2005)

Editorial: Targeting Bruton Tyrosine Kinase
di: Cornelia Brunner, et al.
Pubblicazione: (2022-04-01)

Targeting Bruton’s Tyrosine Kinase in CLL
di: Inhye E. Ahn, et al.
Pubblicazione: (2021-06-01)

Efferocytosis perpetuates substance accumulation inside macrophage populations
di: Ford, HZ, et al.
Pubblicazione: (2019)

NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns
di: Bo Wei, et al.
Pubblicazione: (2024-07-01)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
di: Yang Gyun Kim, et al.
Pubblicazione: (2019-11-01)

Regulatory phosphorylation of Ikaros by Bruton's tyrosine kinase.
di: Hong Ma, et al.
Pubblicazione: (2013-01-01)

Second-generation inhibitors of Bruton tyrosine kinase
di: Jingjing Wu, et al.
Pubblicazione: (2016-09-01)

Bruton’s Tyrosine Kinase and Its Isoforms in Cancer
di: Xianhui Wang, et al.
Pubblicazione: (2021-07-01)

The NLRP3 inflammasome in ischemic stroke
di: Sepiso K. Masenga, et al.
Pubblicazione: (2024-06-01)

Vitamin D and the NLRP3 Inflammasome
di: Matthew Tunbridge, et al.
Pubblicazione: (2020-11-01)

Targeting the NLRP3 Inflammasome in Glaucoma
di: Sophie Coyle, et al.
Pubblicazione: (2021-08-01)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
di: Yao Shen, et al.
Pubblicazione: (2022-08-01)

Pharmacological Inhibitors of the NLRP3 Inflammasome
di: Ayesha Zahid, et al.
Pubblicazione: (2019-10-01)

Role of the NLRP3 Inflammasome in Preeclampsia
di: Koumei Shirasuna, et al.
Pubblicazione: (2020-02-01)

NLRP3 inflammasome in metabolic syndrome
di: Fang Wang, et al.
Pubblicazione: (2021-04-01)

The NLRP1 inflammasome in skin diseases
di: Marc Burian, et al.
Pubblicazione: (2023-02-01)

Role of the NLRP3 inflammasome in cancer
di: Maryam Moossavi, et al.
Pubblicazione: (2018-11-01)

Neurodegenerative Disease and the NLRP3 Inflammasome
di: Jonathan A. Holbrook, et al.
Pubblicazione: (2021-03-01)

Regulation of NLRP3 Inflammasome by Phosphorylation
di: Nan Song, et al.
Pubblicazione: (2018-10-01)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
di: Jiayu Zhang, et al.
Pubblicazione: (2023-10-01)

Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes
di: Purvis, G, et al.
Pubblicazione: (2017)

Inhibition of IκB Kinase at 24 Hours After Acute Kidney Injury Improves Recovery of Renal Function and Attenuates Fibrosis
di: Florence L. Johnson, et al.
Pubblicazione: (2017-07-01)

Tyrosine Dephosphorylation of ASC Modulates the Activation of the NLRP3 and AIM2 Inflammasomes
di: Bezaleel Mambwe, et al.
Pubblicazione: (2019-07-01)

Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
di: Stefania Cannito, et al.
Pubblicazione: (2017-01-01)

Identification of Annexina1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes
di: Purvis, G, et al.
Pubblicazione: (2019)